Meiji Yasuda Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.23M | Hold |
5,005
| – | – | 0.08% | 65 |
|
|
2025
Q4 | $2.27M | Sell |
5,005
-33
| -0.7% | -$14.2K | 0.07% | 63 |
|
|
2025
Q3 | $1.97M | Sell |
5,038
-17
| -0.3% | -$7.11K | 0.06% | 83 |
|
|
2025
Q2 | $2.25M | Sell |
5,055
-20,127
| -80% | -$9.28M | 0.07% | 71 |
|
|
2025
Q1 | $12.2M | Sell |
25,182
-195
| -0.8% | -$90.9K | 0.24% | 42 |
|
|
2024
Q4 | $10.2M | Sell |
25,377
-2,204
| -8% | -$1.02M | 0.19% | 46 |
|
|
2024
Q3 | $12.8M | Sell |
27,581
-1,252
| -4% | -$601K | 0.24% | 42 |
|
|
2024
Q2 | $13.5M | Buy |
28,833
+18,251
| +172% | +$7.92M | 0.27% | 36 |
|
|
2024
Q1 | $4.42M | Buy |
10,582
+751
| +8% | +$317K | 0.09% | 66 |
|
|
2023
Q4 | $4M | Buy |
9,831
+2,384
| +32% | +$881K | 0.09% | 65 |
|
|
2023
Q3 | $2.59M | Buy |
7,447
+1,431
| +24% | +$500K | 0.07% | 73 |
|
|
2023
Q2 | $2.12M | Sell |
6,016
-440
| -7% | -$148K | 0.06% | 86 |
|
|
2023
Q1 | $2.03M | Sell |
6,456
-2,552
| -28% | -$765K | 0.04% | 93 |
|
|
2022
Q4 | $2.6M | Buy |
9,008
+1,049
| +13% | +$320K | 0.06% | 66 |
|
|
2022
Q3 | $2.3M | Buy |
7,959
+1,660
| +26% | +$478K | 0.05% | 69 |
|
|
2022
Q2 | $1.77M | Sell |
6,299
-223
| -3% | -$59.7K | 0.03% | 88 |
|
|
2022
Q1 | $1.7M | Sell |
6,522
-1,053
| -14% | -$250K | 0.03% | 97 |
|
|
2021
Q4 | $1.66M | Buy |
7,575
+153
| +2% | +$29.8K | 0.03% | 106 |
|
|
2021
Q3 | $1.35M | Buy |
7,422
+1,030
| +16% | +$201K | 0.02% | 124 |
|
|
2021
Q2 | $1.29M | Sell |
6,392
-141
| -2% | -$29.5K | 0.02% | 134 |
|
|
2021
Q1 | $1.4M | Sell |
6,533
-80
| -1% | -$17.6K | 0.03% | 117 |
|
|
2020
Q4 | $1.56M | Sell |
6,613
-1,308
| -17% | -$300K | 0.03% | 110 |
|
|
2020
Q3 | $2.15M | Buy |
7,921
+700
| +10% | +$193K | 0.04% | 81 |
|
|
2020
Q2 | $2.1M | Buy |
7,221
+871
| +14% | +$236K | 0.08% | 78 |
|
|
2020
Q1 | $1.51M | Buy |
6,350
+1,453
| +30% | +$333K | 0.3% | 84 |
|
|
2019
Q4 | $1.07M | Sell |
4,897
-1,712
| -26% | -$346K | 0.15% | 152 |
|
|
2019
Q3 | $1.12M | Buy |
6,609
+1,860
| +39% | +$329K | 0.16% | 148 |
|
|
2019
Q2 | $871K | Sell |
4,749
-461
| -9% | -$80.6K | 0.13% | 165 |
|
|
2019
Q1 | $958K | Buy |
5,210
+3,061
| +142% | +$565K | 0.14% | 163 |
|
|
2018
Q4 | $356K | Sell |
2,149
-231
| -10% | -$40K | 0.06% | 268 |
|
|
2018
Q3 | $459K | Buy |
2,380
+1,140
| +92% | +$203K | 0.06% | 273 |
|
|
2018
Q2 | $211K | Sell |
1,240
-1,750
| -59% | -$271K | 0.03% | 308 |
|
|
2018
Q1 | $487K | Buy |
+2,990
| New | +$488K | 0.07% | 226 |
|
|
2017
Q3 | – | Sell |
-3,150
| Closed | -$406K | – | 352 |
|
|
2017
Q2 | $406K | Buy |
+3,150
| New | +$379K | 0.06% | 233 |
|
|
2015
Q1 | – | Sell |
-2,028
| Closed | -$241K | – | 372 |
|
|
2014
Q4 | $241K | Hold |
2,028
| – | – | 0.04% | 360 |
|
|
2014
Q3 | $228K | Buy |
+2,028
| New | +$193K | 0.03% | 359 |
|
Other funds holding VRTX
VCM
VPM
Meiji Yasuda Life Insurance's VRTX Position: Q1 2026 in Review
Meiji Yasuda Life Insurance held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 5,005 shares worth $2.23M. The position accounts for 0.08% of the portfolio, ranked #65.
Meiji Yasuda Life Insurance first reported a position in VRTX in Q3 2014 and has held it in 36 quarters since. The position peaked at $13.5M in Q2 2024. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Meiji Yasuda Life Insurance held 5,005 shares of Vertex Pharmaceuticals worth $2.23M as of Q1 2026.
- Meiji Yasuda Life Insurance left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
- Vertex Pharmaceuticals made up 0.08% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #65 holding.
- Meiji Yasuda Life Insurance first reported a position in Vertex Pharmaceuticals in Q3 2014 and has held it in 36 quarters since.
- Meiji Yasuda Life Insurance's Vertex Pharmaceuticals position peaked at $13.5M in Q2 2024.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.